Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × nimotuzumab × 1 year × Clear all

Phase

Status

Recruiting 9 Not yet recruiting 4 Completed 2 Withdrawn 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 1 Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 17 pembrolizumab 14 Specimen Handling 14 Cyclophosphamide 9 Biopsy 9 fludarabine 8 Radiotherapy 7 Nivolumab 6 Carboplatin 6 atezolizumab 5 Paclitaxel 5 venetoclax 4 niraparib 4 fludarabine phosphate 4 X-Rays 4 Radiosurgery 4 Phantoms, Imaging 4 Cisplatin 4 durvalumab 3 decitabine and cedazuridine drug combination 3 cemiplimab 3 avelumab 3 aldesleukin 3 Standard of Care 3 Radiation 3 Practice Guidelines as Topic 3 Ipilimumab 3 Injections 3 Gemcitabine 3 Fluorouracil 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01345084 2025-03-28

NICAP

Eurofarma Laboratorios S.A.

Phase 3 Withdrawn

Carcinoma, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡